{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:31:30Z","timestamp":1790965890179,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00431-015-2494-8","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T06:08:59Z","timestamp":1422857339000},"page":"949-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial"],"prefix":"10.1007","volume":"174","author":[{"given":"Sameh","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd Elazeez","family":"Shabaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Abdel-Hady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad","family":"Nasef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"2494_CR1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1542\/peds.111.4.914","volume":"111","author":"American Academy of Pediatrics CoFaN","year":"2003","unstructured":"American Academy of Pediatrics CoFaN (2003) Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 111:914\u2013917","journal-title":"Pediatrics"},{"key":"2494_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1542\/peds.107.4.660","volume":"107","author":"J Bauer","year":"2001","unstructured":"Bauer J, Maier K, Linderkamp O, Hentschel R (2001) Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics 107:660\u2013663","journal-title":"Pediatrics"},{"key":"2494_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","volume":"157","author":"JM Fiore Di","year":"2010","unstructured":"Di Fiore JM, Bloom JN, Orge F, Schutt A, Schluchter M, Cheruvu VK, Walsh M, Finer N, Martin RJ (2010) A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 157:69\u201373","journal-title":"J Pediatr"},{"key":"2494_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.resp.2013.05.026","volume":"189","author":"JM Fiore Di","year":"2013","unstructured":"Di Fiore JM, Martin RJ, Gauda EB (2013) Apnea of prematurity\u2014perfect storm. Respir Physiol Neurobiol 189:213\u2013222","journal-title":"Respir Physiol Neurobiol"},{"key":"2494_CR5","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/neo.14-11-e540","volume":"14","author":"NR Dobson","year":"2013","unstructured":"Dobson NR, Hunt CE (2013) Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes. NeoReviews 14:e540\u2013e550","journal-title":"NeoReviews"},{"key":"2494_CR6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","volume":"20","author":"A Erenberg","year":"2000","unstructured":"Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA (2000) Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 20:644\u2013652","journal-title":"Pharmacotherapy"},{"key":"2494_CR7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1460-9592.2001.00753.x","volume":"11","author":"E Ergenekon","year":"2001","unstructured":"Ergenekon E, Dalgic N, Aksoy E, Koc E, Atalay Y (2001) Caffeine intoxication in a premature neonate. Paediatr Anaesth 11:737\u2013739","journal-title":"Paediatr Anaesth"},{"key":"2494_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1754.2010.01943.x","volume":"47","author":"PH Gray","year":"2011","unstructured":"Gray PH, Flenady VJ, Charles BG, Steer PA (2011) Caffeine citrate for very preterm infants: effects on development, temperament and behaviour. J Paediatr Child Health 47:167\u2013172","journal-title":"J Paediatr Child Health"},{"key":"2494_CR9","first-page":"290","volume":"17","author":"JM Gupta","year":"1981","unstructured":"Gupta JM, Mercer HP, Koo WW (1981) Theophylline in treatment of apnoea of prematurity. Aust Paediatr J 17:290\u2013291","journal-title":"Aust Paediatr J"},{"key":"2494_CR10","volume-title":"Pulmonary disease in the newborn. In: Textbook of neonatology","author":"D Henderson-Smart","year":"1986","unstructured":"Henderson-Smart D (1986) Pulmonary disease in the newborn. In: Textbook of neonatology. Churchill livingstone, Melbourne"},{"key":"2494_CR11","first-page":"273","volume":"17","author":"DJ Henderson-Smart","year":"1981","unstructured":"Henderson-Smart DJ (1981) The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust Paediatr J 17:273\u2013276","journal-title":"Aust Paediatr J"},{"key":"2494_CR12","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ, and Davis PG (2010). Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev CD000139","DOI":"10.1002\/14651858.CD000139.pub2"},{"key":"2494_CR13","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ, and De Paoli AG (2010). Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev CD000140","DOI":"10.1002\/14651858.CD000140.pub2"},{"key":"2494_CR14","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ, and Steer PA (2010). Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev CD000273.","DOI":"10.1002\/14651858.CD000273.pub2"},{"key":"2494_CR15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1651-2227.2007.00618.x","volume":"97","author":"AO Hofstetter","year":"2008","unstructured":"Hofstetter AO, Legnevall L, Herlenius E, Katz-Salamon M (2008) Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term-equivalent age. Acta Paediatr 97:285\u2013292","journal-title":"Acta Paediatr"},{"key":"2494_CR16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723\u20131729","journal-title":"Am J Respir Crit Care Med"},{"key":"2494_CR17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00431-009-0961-9","volume":"168","author":"Z Kassim","year":"2009","unstructured":"Kassim Z, Greenough A, Rafferty GF (2009) Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 168:1491\u20131495","journal-title":"Eur J Pediatr"},{"key":"2494_CR18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1460-9592.1996.d01-10.x","volume":"6","author":"D Kibblewhite","year":"1996","unstructured":"Kibblewhite D, Sleigh J (1996) Heart rate variability in premature neonates pre and post methylxanthine administration. Pediatr Anesth 6:399\u2013403","journal-title":"Pediatr Anesth"},{"key":"2494_CR19","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/j.1651-2227.2012.02664.x","volume":"101","author":"A Kumral","year":"2012","unstructured":"Kumral A, Tuzun F, Yesilirmak DC, Duman N, Ozkan H (2012) Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr 101:e299\u2013e303","journal-title":"Acta Paediatr"},{"key":"2494_CR20","unstructured":"Martin RJ, Abu-Shaweesh JM, and Baird TM (2004). Apnoea of prematurity. Paediatr Respir Rev 5 Suppl A: S377-382."},{"key":"2494_CR21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000329922","volume":"100","author":"RJ Martin","year":"2011","unstructured":"Martin RJ, Wang K, Koroglu O, Di Fiore J, Kc P (2011) Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology 100:303\u2013310","journal-title":"Neonatology"},{"key":"2494_CR22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jp.2010.126","volume":"31","author":"OP Mathew","year":"2011","unstructured":"Mathew OP (2011) Apnea of prematurity: pathogenesis and management strategies. J Perinatol 31:302\u2013310","journal-title":"J Perinatol"},{"key":"2494_CR23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3476(81)80038-8","volume":"99","author":"I Murat","year":"1981","unstructured":"Murat I, Moriette G, Blin MC, Couchard M, Flouvat B, De Gamarra E, Relier JP, Dreyfus-Brisac C (1981) The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 99:984\u2013989","journal-title":"J Pediatr"},{"key":"2494_CR24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3476(05)81620-8","volume":"116","author":"A Peliowski","year":"1990","unstructured":"Peliowski A, Finer NN (1990) A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr 116:648\u2013653","journal-title":"J Pediatr"},{"key":"2494_CR25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.104.080432","volume":"313","author":"T Rieg","year":"2005","unstructured":"Rieg T, Steigele H, Schnermann J, Richter K, Osswald H, Vallon V (2005) Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 313:403\u2013409","journal-title":"J Pharmacol Exp Ther"},{"key":"2494_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pediatrneurol.2008.09.017","volume":"40","author":"CM Robertson","year":"2009","unstructured":"Robertson CM, Watt MJ, Dinu IA (2009) Outcomes for the extremely premature infant: what is new? And where are we going? Pediatr Neurol 40:189\u2013196","journal-title":"Pediatr Neurol"},{"key":"2494_CR27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/adc.67.4_Spec_No.425","volume":"67","author":"JE Scanlon","year":"1992","unstructured":"Scanlon JE, Chin KC, Morgan ME, Durbin GM, Hale KA, Brown SS (1992) Caffeine or theophylline for neonatal apnoea? Arch Dis Child 67:425\u2013428","journal-title":"Arch Dis Child"},{"key":"2494_CR28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2011.2024","volume":"307","author":"B Schmidt","year":"2012","unstructured":"Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS (2012) Survival without disability to age 5\u00a0years after neonatal caffeine therapy for apnea of prematurity. JAMA 307:275\u2013282","journal-title":"JAMA"},{"key":"2494_CR29","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2006) Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112\u20132121","journal-title":"N Engl J Med"},{"key":"2494_CR30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2007) Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357:1893\u20131902","journal-title":"N Engl J Med"},{"key":"2494_CR31","first-page":"567","volume":"139","author":"ME Sims","year":"1985","unstructured":"Sims ME, Yau G, Rambhatla S, Cabal L, Wu PY (1985) Limitations of theophylline in the treatment of apnea of prematurity. Am J Dis Child 139:567\u2013570","journal-title":"Am J Dis Child"},{"key":"2494_CR32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/jp.2008.193","volume":"29","author":"V Soloveychik","year":"2009","unstructured":"Soloveychik V, Bin-Nun A, Ionchev A, Sriram S, Meadow W (2009) Acute hemodynamic effects of caffeine administration in premature infants. J Perinatol 29:205\u2013208","journal-title":"J Perinatol"},{"key":"2494_CR33","doi-asserted-by":"crossref","first-page":"F499","DOI":"10.1136\/adc.2002.023432","volume":"89","author":"P Steer","year":"2004","unstructured":"Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, Bury G, Fraser S, Hegarty J, Rogers Y, Reid S, Horton L, Charlton M, Jacklin R, Walsh A (2004) High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 89:F499\u2013F503","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2494_CR34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1440-1754.2003.00207.x","volume":"39","author":"PA Steer","year":"2003","unstructured":"Steer PA, Flenady VJ, Shearman A, Lee TC, Tudehope DI, Charles BG (2003) Periextubation caffeine in preterm neonates: a randomized dose response trial. J Paediatr Child Health 39:511\u2013515","journal-title":"J Paediatr Child Health"},{"key":"2494_CR35","unstructured":"Shah VA, and Wai WC (2011). Effectivenes and side effects of 2 different doses of caffeine citrate in preventing apnea in VLBW premature infants. In: Hot Topics in Neonatology. Washington\/DC: Nemours Education"},{"key":"2494_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","volume":"33","author":"MC Walsh","year":"1986","unstructured":"Walsh MC, Kliegman RM (1986) Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33:179\u2013201","journal-title":"Pediatr Clin North Am"},{"key":"2494_CR37","first-page":"470","volume":"15","author":"AB Zubrow","year":"1995","unstructured":"Zubrow AB, Hulman S, Kushner H, Falkner B (1995) Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol 15:470\u2013479","journal-title":"J Perinatol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2494-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-015-2494-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2494-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:32:05Z","timestamp":1559082725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-015-2494-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2494"],"URL":"https:\/\/doi.org\/10.1007\/s00431-015-2494-8","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}